Independent Advisor Alliance’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $217K | Sell |
1,186
-4,801
| -80% | -$885K | ﹤0.01% | 1462 |
|
|
2025
Q4 | $1.05M | Buy |
5,987
+3,816
| +176% | +$623K | 0.03% | 457 |
|
|
2025
Q3 | $304K | Buy |
+2,171
| New | +$293K | 0.01% | 764 |
|
|
2025
Q2 | – | Sell |
-2,008
| Closed | -$275K | – | 896 |
|
|
2025
Q1 | $275K | Sell |
2,008
-461
| -19% | -$65.9K | 0.01% | 677 |
|
|
2024
Q4 | $378K | Sell |
2,469
-5,820
| -70% | -$982K | 0.01% | 1045 |
|
|
2024
Q3 | $1.61M | Sell |
8,289
-1,843
| -18% | -$386K | 0.06% | 254 |
|
|
2024
Q2 | $2.35M | Buy |
10,132
+789
| +8% | +$171K | 0.08% | 202 |
|
|
2024
Q1 | $2.01M | Buy |
9,343
+292
| +3% | +$68.4K | 0.07% | 218 |
|
|
2023
Q4 | $2.34M | Buy |
9,051
+363
| +4% | +$89.2K | 0.08% | 192 |
|
|
2023
Q3 | $2.23M | Buy |
8,688
+1,365
| +19% | +$365K | 0.1% | 183 |
|
|
2023
Q2 | $2.09M | Buy |
7,323
+25
| +0.3% | +$7.44K | 0.09% | 183 |
|
|
2023
Q1 | $2.03M | Buy |
+7,298
| New | +$2.02M | 0.1% | 188 |
|
|
2022
Q4 | – | Sell |
-6,570
| Closed | -$1.75M | – | 447 |
|
|
2022
Q3 | $1.75M | Buy |
6,570
+314
| +5% | +$66.7K | 0.1% | 188 |
|
|
2022
Q2 | $1.28M | Buy |
6,256
+5,074
| +429% | +$1.04M | 0.07% | 226 |
|
|
2022
Q1 | $249K | Buy |
1,182
+102
| +9% | +$22.2K | 0.01% | 548 |
|
|
2021
Q4 | $259K | Sell |
1,080
-320
| -23% | -$82.3K | 0.01% | 559 |
|
|
2021
Q3 | $396K | Buy |
1,400
+123
| +10% | +$40.3K | 0.02% | 429 |
|
|
2021
Q2 | $442K | Sell |
1,277
-25
| -2% | -$7.57K | 0.02% | 419 |
|
|
2021
Q1 | $364K | Sell |
1,302
-22
| -2% | -$5.93K | 0.02% | 442 |
|
|
2020
Q4 | $324K | Buy |
1,324
+377
| +40% | +$97.3K | 0.02% | 422 |
|
|
2020
Q3 | $269K | Buy |
+947
| New | +$264K | 0.02% | 403 |
|
|
2020
Q2 | – | Sell |
-637
| Closed | -$202K | – | 497 |
|
|
2020
Q1 | $202K | Buy |
+637
| New | +$193K | 0.03% | 360 |
|
|
2019
Q2 | – | Sell |
-1,023
| Closed | -$242K | – | 427 |
|
|
2019
Q1 | $242K | Buy |
1,023
+104
| +11% | +$32.7K | 0.03% | 360 |
|
|
2018
Q4 | $277K | Sell |
919
-384
| -29% | -$123K | 0.05% | 303 |
|
|
2018
Q3 | $392K | Sell |
1,303
-3,460
| -73% | -$1.19M | 0.07% | 223 |
|
|
2018
Q2 | $1.33M | Buy |
4,763
+3,629
| +320% | +$1.02M | 0.28% | 88 |
|
|
2018
Q1 | $304K | Sell |
1,134
-742
| -40% | -$230K | 0.07% | 247 |
|
|
2017
Q4 | $618K | Buy |
1,876
+826
| +79% | +$265K | 0.14% | 163 |
|
|
2017
Q3 | $346K | Buy |
+1,050
| New | +$311K | 0.1% | 188 |
|
Other funds holding BIIB
VCM
VPM
Independent Advisor Alliance's BIIB Position: Q1 2026 in Review
Independent Advisor Alliance reduced its Biogen (BIIB) stake by 80% in Q1 2026, selling an estimated $885K and leaving 1,186 shares worth $217K. The position accounts for ﹤0.01% of the portfolio, ranked #1462.
Independent Advisor Alliance first reported a position in BIIB in Q3 2017 and has held it in 29 quarters since. The position peaked at $2.35M in Q2 2024. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.
- Independent Advisor Alliance held 1,186 shares of Biogen worth $217K as of Q1 2026.
- Independent Advisor Alliance sold 4,801 Biogen shares in Q1 2026, an estimated $885K.
- Biogen made up ﹤0.01% of Independent Advisor Alliance's portfolio in Q1 2026, its #1462 holding.
- Independent Advisor Alliance first reported a position in Biogen in Q3 2017 and has held it in 29 quarters since.
- Independent Advisor Alliance's Biogen position peaked at $2.35M in Q2 2024.
- 1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.
Based on Independent Advisor Alliance's 13F filing for Q1 2026, filed 12 May 2026.